MENATETRENONE for Procoagulant therapy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where MENATETRENONE was used for Procoagulant therapy.
Most Reported Side Effects for MENATETRENONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 7 | 19.4% | 0 | 0 |
| Adenovirus infection | 5 | 13.9% | 0 | 5 |
| Diarrhoea | 5 | 13.9% | 0 | 5 |
| Graft versus host disease | 5 | 13.9% | 0 | 5 |
| Hepatic function abnormal | 5 | 13.9% | 0 | 5 |
| Hyperglycaemia | 5 | 13.9% | 0 | 5 |
| Ileus paralytic | 5 | 13.9% | 0 | 5 |
| Pneumothorax | 5 | 13.9% | 0 | 5 |
| Respiratory disorder | 5 | 13.9% | 0 | 5 |
| Thrombotic microangiopathy | 5 | 13.9% | 0 | 5 |
Other Indications for MENATETRENONE
Other Drugs Used for Procoagulant therapy
IDARUCIZUMAB (1,040)
ANDEXANET ALFA (272)
PROTAMINE (152)
COAGULATION FACTOR IX HUMAN\COAGULATION FACTOR VII HUMAN\COAGULATION FACTOR X HUMAN\PROTEIN C\PROTEIN S HUMAN\PROTHROMBIN (128)
COAGULATION FACTOR IX HUMAN\COAGULATION FACTOR VII HUMAN\COAGULATION FACTOR X HUMAN\PROTHROMBIN (97)
TRANEXAMIC ACID (40)
PHYTONADIONE (18)
ANTI-INHIBITOR COAGULANT COMPLEX (16)
EPLERENONE (14)
AMINOCAPROIC ACID (9)